| Coffman Vision Clinic Inc | |
|
61535 S Highway 97, Ste. 16, Bend, OR 97702-2154 | |
| (541) 389-4774 | |
| (541) 389-3971 |
| Full Name | Coffman Vision Clinic Inc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 61535 S Highway 97, Bend, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811064967 | NPI | - | NPPES |
| 1982799789 | Other | OR | INDIVIDUAL NPI |
| R116227 | Other | OR | MEDICARE GROUP # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2508T (Oregon) | Primary |
| Provider Name | Ronald R Guiley |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1619913944 PECOS PAC ID: 1456451426 Enrollment ID: I20070705000638 |
News Archive
NexMed, Inc. (Nasdaq: NEXM), a developer of innovative topical products based on the NexACT® technology, today announced that it has submitted to Nasdaq its plan to achieve and sustain compliance with Marketplace Rule 4310(c)(3).
Scientists from the Farncombe Family Digestive Health Research Institute at McMaster University have discovered that intestinal bacteria play an important role in inducing anxiety and depression.
Researchers tested the nasopharyngeal microbiome of children up to 21 years old and found the microbiome changes with age. Specific bacteria, whose abundance also changes with age, are associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection susceptibility and severity.
In vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI. Growth of equipment sales is on track to reach $400 million in 2014 and nearly $1 billion by the end of the decade.
› Verified 4 days ago
| Provider Name | Michael A Coffman |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1982799789 PECOS PAC ID: 3577557354 Enrollment ID: I20101004001481 |
News Archive
NexMed, Inc. (Nasdaq: NEXM), a developer of innovative topical products based on the NexACT® technology, today announced that it has submitted to Nasdaq its plan to achieve and sustain compliance with Marketplace Rule 4310(c)(3).
Scientists from the Farncombe Family Digestive Health Research Institute at McMaster University have discovered that intestinal bacteria play an important role in inducing anxiety and depression.
Researchers tested the nasopharyngeal microbiome of children up to 21 years old and found the microbiome changes with age. Specific bacteria, whose abundance also changes with age, are associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection susceptibility and severity.
In vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI. Growth of equipment sales is on track to reach $400 million in 2014 and nearly $1 billion by the end of the decade.
› Verified 4 days ago
| Provider Name | Erin E Follen |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1255683595 PECOS PAC ID: 6204142136 Enrollment ID: I20150908002532 |
News Archive
NexMed, Inc. (Nasdaq: NEXM), a developer of innovative topical products based on the NexACT® technology, today announced that it has submitted to Nasdaq its plan to achieve and sustain compliance with Marketplace Rule 4310(c)(3).
Scientists from the Farncombe Family Digestive Health Research Institute at McMaster University have discovered that intestinal bacteria play an important role in inducing anxiety and depression.
Researchers tested the nasopharyngeal microbiome of children up to 21 years old and found the microbiome changes with age. Specific bacteria, whose abundance also changes with age, are associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection susceptibility and severity.
In vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI. Growth of equipment sales is on track to reach $400 million in 2014 and nearly $1 billion by the end of the decade.
› Verified 4 days ago
| Provider Name | Tonya R. Hubbard |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1275580896 PECOS PAC ID: 9133139850 Enrollment ID: I20150917000292 |
News Archive
NexMed, Inc. (Nasdaq: NEXM), a developer of innovative topical products based on the NexACT® technology, today announced that it has submitted to Nasdaq its plan to achieve and sustain compliance with Marketplace Rule 4310(c)(3).
Scientists from the Farncombe Family Digestive Health Research Institute at McMaster University have discovered that intestinal bacteria play an important role in inducing anxiety and depression.
Researchers tested the nasopharyngeal microbiome of children up to 21 years old and found the microbiome changes with age. Specific bacteria, whose abundance also changes with age, are associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection susceptibility and severity.
In vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI. Growth of equipment sales is on track to reach $400 million in 2014 and nearly $1 billion by the end of the decade.
› Verified 4 days ago
| Provider Name | Melissa L Prickett |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1346423753 PECOS PAC ID: 6204906563 Enrollment ID: I20230103002569 |
News Archive
NexMed, Inc. (Nasdaq: NEXM), a developer of innovative topical products based on the NexACT® technology, today announced that it has submitted to Nasdaq its plan to achieve and sustain compliance with Marketplace Rule 4310(c)(3).
Scientists from the Farncombe Family Digestive Health Research Institute at McMaster University have discovered that intestinal bacteria play an important role in inducing anxiety and depression.
Researchers tested the nasopharyngeal microbiome of children up to 21 years old and found the microbiome changes with age. Specific bacteria, whose abundance also changes with age, are associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection susceptibility and severity.
In vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI. Growth of equipment sales is on track to reach $400 million in 2014 and nearly $1 billion by the end of the decade.
› Verified 4 days ago
| Provider Name | Trevor Lee Jones |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1609454891 PECOS PAC ID: 7810352838 Enrollment ID: I20230426003007 |
News Archive
NexMed, Inc. (Nasdaq: NEXM), a developer of innovative topical products based on the NexACT® technology, today announced that it has submitted to Nasdaq its plan to achieve and sustain compliance with Marketplace Rule 4310(c)(3).
Scientists from the Farncombe Family Digestive Health Research Institute at McMaster University have discovered that intestinal bacteria play an important role in inducing anxiety and depression.
Researchers tested the nasopharyngeal microbiome of children up to 21 years old and found the microbiome changes with age. Specific bacteria, whose abundance also changes with age, are associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection susceptibility and severity.
In vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI. Growth of equipment sales is on track to reach $400 million in 2014 and nearly $1 billion by the end of the decade.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Coffman Vision Clinic Inc 61535 S Highway 97, Ste. 16, Bend, OR 97702-2154 Ph: (541) 389-4774 | Coffman Vision Clinic Inc 61535 S Highway 97, Ste. 16, Bend, OR 97702-2154 Ph: (541) 389-4774 |
News Archive
NexMed, Inc. (Nasdaq: NEXM), a developer of innovative topical products based on the NexACT® technology, today announced that it has submitted to Nasdaq its plan to achieve and sustain compliance with Marketplace Rule 4310(c)(3).
Scientists from the Farncombe Family Digestive Health Research Institute at McMaster University have discovered that intestinal bacteria play an important role in inducing anxiety and depression.
Researchers tested the nasopharyngeal microbiome of children up to 21 years old and found the microbiome changes with age. Specific bacteria, whose abundance also changes with age, are associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection susceptibility and severity.
In vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI. Growth of equipment sales is on track to reach $400 million in 2014 and nearly $1 billion by the end of the decade.
› Verified 4 days ago
Elena Talea, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1470 Sw Knoll Ave Ste 102, Bend, OR 97702 Phone: 541-797-0295 | |
Eyes In Motion Optometrist Medicare: Not Enrolled in Medicare Practice Location: 20120 Pinebrook Blvd, Bend, OR 97702 Phone: 541-389-2508 Fax: 541-389-2973 | |
Mrs. Elizabeth A Potvin, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2450 Ne Mary Rose Pl, Suite 110, Bend, OR 97701 Phone: 541-318-8388 | |
Dr. Joseph J Kvortek, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3044 N Highway 97, Bend, OR 97701 Phone: 541-388-5716 Fax: 541-617-7898 | |
Christopher Carmiencke, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 452 Ne Greenwood Ave, Bend, OR 97701 Phone: 541-382-5701 Fax: 541-382-5702 | |
Dr. Eric Hinds, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 63455 N Highway 97 Ste 75, Bend, OR 97703 Phone: 541-389-5207 | |
Cascade Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 62968 O B Riley Rd Ste 11, Bend, OR 97703 Phone: 541-382-2020 Fax: 541-382-5004 |